Artificial Heart Lung Machine Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: LivaNova, Getinge, Medtronic, Tianjin Medical

The global Artificial Heart Lung Machine market size is expected to grow at US$ 339.5 million in 2027 at a compound annual growth rate (CAGR) of 4.9%.

Artificial Heart Lung Machine Market Overview

In open-heart surgery, an artificial heart-lung system is used to support the appropriate functioning of the heart and body during the procedure. A chamber in the heart-lung machine collects blood from the body, oxygenates it, and then distributes it to every region of the body. A number of tubes are used to attach the machine to the patient; these tubes are subsequently cut once the surgery is over and the patient's heart and lungs are operating normally. The frequency of open-heart surgeries, heart transplants, and lung operations has significantly increased in recent years all around the world. This is mostly due to a number of environmental and lifestyle modifications that have increased the frequency of cardiovascular illnesses and the occurrence of organ failure. In addition, governments in a number of developing countries are working to enhance patient access to healthcare, which is increasing demand for artificial heart-lung machines. Additionally, industry participants are spending money on R&D projects to update the oxygenator pumps that are currently on the market. Modular heart-lung machines that are affordable, secure, and easy to use have been developed as a result of these initiatives. In addition, since these devices are portable and run-on rechargeable batteries, they give doctors more freedom. CPB pumps have also undergone a number of upgrades from the manufacturers to stop blood from being over oxygenated.

Industry News and Updates

JUL 28, 2021: Medtronic Announces FDA Clearance and Results of Artificial Intelligence Algorithms for Cardiac Monitoring --

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced U.S. Food and Drug Administration (FDA) clearance for two AccuRhythm™ AI algorithms for use with the LINQ II™ insertable cardiac monitor (ICM). AccuRhythm AI applies artificial intelligence (AI) to heart rhythm event data collected by LINQ II, improving the accuracy of information physicians receive so they can better diagnose and treat abnormal heart rhythms. AccuRhythm AI validation data will be presented this week at Heart Rhythm 2021, the Heart Rhythm Society's annual Heart Rhythm meeting.

What are the major Applications, Types and Regions for Artificial Heart Lung Machine Market?

Market is segmented based on the type, applications, companies and regions.

By Type, it is segmented into

• Single Roller Pump HLM


• Double Roller Pump HLM

By Application, it is segmented into

• Cardiac Surgery


• Lung Transplant Operation


• Acute Respiratory Failure Treatment


• Others

Artificial Heart Lung Machine Market Regional Analysis

North America dominated the global artificial heart-lung machine market in 2018 and is expected to have a substantial market share over the forecast period (2020-2027) due to rising cardiovascular disease occurrences, quick technical breakthroughs, increased public awareness, and a growing demand for minimally invasive operations. The increased prevalence of cardiovascular illnesses is likely to boost the market during the forecast period. For instance, the American College of Cardiology estimates that 800,000 fatalities in the US occurred as a direct result of cardiovascular disease in 2017. Additionally, every 40 seconds, one American perishes from a cardiovascular condition. The majority of CVD fatalities are caused by coronary heart disease, followed by stroke and heart failure. According to the CDC, heart disease is the leading cause of death in the United States, accounting for one in every four fatalities each year. Nearly 6 million Americans already suffer heart failure, and by 2030, that number is projected to rise by 46% to 8 million. Therefore, the market is being driven by the rise in cardiovascular illnesses.

• North America
  
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East & Africa
  
  
  • Latin America
  
  
  
  

The Artificial Heart Lung Machine Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Artificial Heart Lung Machine Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

What is our Artificial Heart Lung Machine Market report scope?

Key Takeaways from this Artificial Heart Lung Machine Market Report

• Evaluate Artificial Heart Lung Machine market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.


• Understand the different dynamics influencing the market - growth driving factors, specific challenges and hidden opportunities.


• Get in-depth insights on your competitor performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis and more.


• Analyze the sales and distribution channels across geographies to enhance top-line revenues.


• Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies in your processes.


• Get a quick outlook on the Artificial Heart Lung Machine market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.


• Evaluate the import-export statistics, supply-demand and competitive landscape for more than top 20 countries globally for the market.

Frequently Asked Questions

What is the growth rate of Artificial Heart Lung Machine Market?

The Artificial Heart Lung Machine Market is growing at a CAGR of 4.9% over the next 5 years.

Who are the key players in Artificial Heart Lung Machine Market?

LivaNova, Getinge, Medtronic, Tianjin Medical, Medtronic Inc., Sorin Group, MAQUET GmbH & Co. KG, Terumo Corporation, C. R. Bard Inc., Edwards Lifesciences, Braile Biomedica, SynCardia, Jarvik Heart

What are the significant types of Artificial Heart Lung Machine Market?

Single Roller Pump HLM, Double Roller Pump HLM

What are the major end-use applications of Artificial Heart Lung Machine Market?

Cardiac Surgery, Lung Transplant Operation, Acute Respiratory Failure Treatment, Others

All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.